Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Enriched Ringers Lactate Solution

Research Leaders

7 sponsors active, led by Lifetech Scientific (Shenzhen) Co., Ltd.

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
Phase 4 (1)

Trial Status

Completed3
Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Enriched Ringers Lactate Solution1
  • Multibranched Thoracoabdominal Stent Graft System1
  • Endovascular Repair1
  • Custodiol1
  • The System Includes The Gbranch Thoracoabdominal Aortic Stent Graft System The Peripheral Vascular Stent Graft System And The Aortic Extension Stent Graft System1

Active Sponsors

  • Lifetech Scientific (Shenzhen) Co., Ltd.2
  • University of South Florida1
  • Scientific Institute San Raffaele1
  • Sanford Health1
  • IRCCS San Raffaele1

Top Investigators

Activity Timeline